Sharepoint Solutions
PRODUCTS
-
Werum PAS-X as a Service delivers a fully managed, cloud-based MES for pharma and biotech, enabling rapid deployment, scalability, cost savings, compliance, and operational efficiency.
-
Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.
-
Our goal is to help your business succeed by working with you to streamline the FDA regulatory process. ProPharma’s team of science- based regulatory consultants commands an unparalleled breadth and depth of knowledge pertaining to FDA’s regulatory framework and can work with you to accomplish your business objectives.
-
The DecFill LM-200 and DecFill LM-560 are compact, fully automatic labeling machines designed for the automated labeling of vials, bottles, syringes, ampules, cartridges, and other containers with self-adhesive labels.
-
At 120Water, we take the weight off the shoulders of our clients. From expert guidance and best practices to a proven activation process, we help ensure your program achieves ongoing success.
WHITE PAPERS AND CASE STUDIES
-
Project Orbis Drug Registration 2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
-
Newport News, VA Deploys 130,000 Mueller AMI Meters
Eight years ago, Newport News started having discussions about moving away from reading their mechanical, manually read meters every other month to go to monthly billing. Knowing they did not have adequate staffing to handle that task, the department decided to outsource its meter reading responsibilities to a third party.
-
A Strategic Guide For Biotech And Biopharma Leaders
Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.
-
Antibody Coverage Analysis Of E. coli HCPs In The BL21(DE3) Strain
Review a study conducted to determine the suitability and similarity of Cygnus E. coli HCP ELISA Kits to quantify BL21(DE3) Host Cell Proteins (HCPs).
-
Rescuing A Global Program For NDA Success
Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
Patient-Focused Data Capture For Cancer Research
In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.
-
Cleanroom Recovery. Proven Results. Contamination Control Case Studies
Through this collection, review how a proven, automated solution can help facilities stay compliant, operational, and protected — whether in a crisis or during planned maintenance.
-
Enabling CDMOs To Focus On Core Priorities
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
Advancing In Silico Predictions In Early Drug Discovery
Examine a high-throughput approach that streamlines LogD measurements, offering faster and more accurate insight into compound lipophilicity to support better decision-making in early drug discovery.
-
Thales Receives Custom 10PW Beam Dump For World's Most Powerful Laser
By collaborating with Gentec-EO and their distributor Laser Components, see how Thales was able to gather the necessary specifications and requirements for this project.
-
Clinical Trial Starts Rose At Slower Pace In 2024
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
NEWS
-
Axim Biotechnologies Files Pre-Submission With FDA For CLIA Waiver Pathway On Lactoferrin Point-Of-Care Diagnostic Test6/24/2025
Axim Biotechnologies, Inc. a leading developer of rapid diagnostic testing for ocular and systemic conditions, today announced that it has filed a Pre-Submission (Pre-Sub Q) with the U.S. Food and Drug Administration (FDA) as the first formal step in seeking a Clinical Laboratory Improvement Amendments (CLIA) Waiver for its rapid, point-of-care Lactoferrin diagnostic test (TearScan Lf).
-
New Report Introduces First Legal Blueprint For Climate-Resilient Water And Sanitation In The U.S.11/19/2025
A new report released today by the Pacific Institute and the Center for Water Security and Cooperation (CWSC) provides the most comprehensive framework to date for assessing and improving whether laws enable climate-resilient U.S. water and sanitation systems.
-
Partnerships Drive Wheat Production And Livelihoods In Zimbabwe9/3/2025
Phaphamani Irrigation Scheme in Umguza District, Matabeleland North Province, Zimbabwe, yesterday showcased the transformative power of strong partnerships in boosting wheat production and improving rural livelihoods.
-
Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency12/19/2025
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.
-
Global Hydrogen Market: Uniper And thyssenkrupp Uhde Sign Framework Agreement On The Use Of Ammonia Cracking Technology11/26/2025
Uniper and thyssenkrupp Uhde have signed a framework agreement that lays the foundation for the construction of commercial ammonia cracking plants.